Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $2.54 ($507,949)
  2. 4 Open-market buy CEO & Chairman bought 350,000 shares at an average $2.29 ($802,103)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Chief Innovation Officer bought 240,000 shares at an average $2.49 ($597,393)
  11. 4/A Grant or award Chief Innovation Officer acquired 39,555,028 shares (grant or award)
  12. 4/A Grant or award Vice Chairman and President acquired 39,555,028 shares (grant or award)
  13. 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $2.39 ($478,857)
  14. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.31 ($231,327)
  15. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.36 ($236,498)
  16. 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $2.79 ($279,227)
  17. 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.95 ($147,614)
  18. 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $3.02 ($151,177)
  19. 4 Open-market buy CEO & Chairman bought 50,000 shares at an average $2.98 ($148,866)
  20. 4 Open-market buy Chief Innovation Officer bought 75,471 shares at an average $2.88 ($217,121)

Page 8 of 106 · 2,118 filings